Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 May 7;64(1):12.
doi: 10.1186/s13028-022-00630-5.

Elimination of porcine reproductive and respiratory syndrome virus infection using an inactivated vaccine in combination with a roll-over method in a Hungarian large-scale pig herd

Attila Pertich  1 , Zoltán Barna  1 , Orsolya Makai  1 , János Farkas  1 , Tamás Molnár  2 , Ádám Bálint  3 , István Szabó  2 , Mihály Albert  4
Affiliations
Case Reports

Elimination of porcine reproductive and respiratory syndrome virus infection using an inactivated vaccine in combination with a roll-over method in a Hungarian large-scale pig herd

Attila Pertich et al. Acta Vet Scand. .

Abstract

Background: Porcine reproductive and respiratory syndrome virus (PRRSV) causes severe economic losses worldwide and only four countries in Europe are free from PRRSV. Complete depopulation-repopulation is the safest and fastest, but also the most expensive method for eradicating PRRSV from a population. Another possible way to eliminate an endemic PRRSV infection is to replace the infected breeding stock by gilts reared isolated and protected from PRRSV on an infected farm. With this method it is possible to maintain continuous production on the farm. The authors report the first successful elimination of PRRSV in a Hungarian large-scale pig farm by using an inactivated vaccine and performing segregated rearing of the offspring.

Case presentation: The study was performed on a PRRSV infected farm (Farm A) with 1475 sows. The clinical signs of reproductive failure had been eliminated previously by using an inactivated vaccine (Progressis®, Ceva). At the beginning of the elimination programme, gilts intended for breeding were vaccinated at 60 and 90-100 days of age. After that, gilts selected for breeding were vaccinated at 6 months of age, on the 60-70th day of pregnancy and at weaning. Approximately 1200 piglets from vaccinated sows were transported at 7 weeks of age to a closed, empty farm (Farm B) after being tested negative for PRRSV by a polymerase chain reaction (PCR) method, and then were reared here until 14 weeks of age. At this age, all pigs were tested by PRRS ELISA. Seronegative gilts (n = 901) were subsequently transported from Farm B to a third, closed and empty farm (Farm C), and (having reached the breeding age) they were inseminated here after a second negative serological test (ELISA). At the same time, Farm A was depopulated, cleaned and disinfected. All pregnant gilts were transported from Farm C to Farm A after being re-tested negative for antibodies against PRRSV. Follow-up serology tests were performed after farrowing and results yielded only seronegative animals. Based on the subsequent negative test results, the herd was declared PRRSV free by the competent authority.

Conclusions: The presented farm was the first during the National PRRS Eradication Programme of Hungary to eradicate PRRSV successfully by vaccinating the sows with an inactivated vaccine and performing segregated rearing of the offspring. Production was almost continuous during the whole process of population replacement.

Keywords: Elimination; Inactivated vaccine; PRRS; Progressis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests. MA is employee of Ceva Phylaxia, the producer of the vaccine used (Progressis®).

Figures

Fig. 1
Fig. 1
Distribution of sows according to parity (P) in Farm A end of 2014 when the PRRSV eradication programme was in initiated. Numbers in the figure refer to number of sows
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Holtkamp DJ, Kliebenstein JB, Neumann E, Zimmerman JJ. Assessment of the economic impact of porcine reproductive and respiratory syndrome virus on United States pork producers. J Swine Health Prod. 2013;21:72–84.
    1. Jung-Ah L, Nak-Hyung L, Joong-Bok L, Seung-Yong P, Chang-Seon S, In-Soo C, et al. Augmented immune responses in pigs immunized with an inactivated porcine reproductive and respiratory syndrome virus containing the deglycosylated glycoprotein 5 under field conditions. Clin Exp Vaccine Res. 2016;5:70–74. doi: 10.7774/cevr.2016.5.1.70. - DOI - PMC - PubMed
    1. Balka G, Dreckmann K, Papp G, Kraft C. Vaccination of piglets at 2 and 3 weeks of age with Ingelvac PRRSFLEX® EU provides protection against heterologous field challenge in the face of homologous maternally derived antibodies. Porc Health Manag. 2016;2:24. doi: 10.1186/s40813-016-0037-y. - DOI - PMC - PubMed
    1. Nathues H, Alarcon P, Rushton J, Jolie R, Fiebig K, Jimenez M, et al. Modelling the economic efficiency of using different strategies to control porcine reproductive & respiratory syndrome at herd level. Prev Vet Med. 2018;152:89–102. doi: 10.1016/j.prevetmed.2018.02.005. - DOI - PubMed
    1. Berton P, Normand V, Martineau GP, Bouchet F, Lebret A, Waret-Szkuta A. Evaluation of porcine reproductive and respiratory syndrome stabilization protocols in 23 French Farrow-to-finish farms located in a high-density swine area. Porc Health Manag. 2017;3:11. doi: 10.1186/s40813-017-0058-1. - DOI - PMC - PubMed

Publication types

LinkOut - more resources